OM
Opaleye Management’s UroGen Pharma URGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-220,000
| Closed | -$2.34M | – | 54 |
|
|
2024
Q4 | $2.34M | Sell |
220,000
-184,100
| -46% | -$1.96M | 0.41% | 30 |
|
|
2024
Q3 | $5.13M | Sell |
404,100
-7,900
| -2% | -$100K | 0.86% | 24 |
|
|
2024
Q2 | $6.91M | Buy |
412,000
+142,000
| +53% | +$2.38M | 1.58% | 21 |
|
|
2024
Q1 | $4.05M | Sell |
270,000
-50,000
| -16% | -$750K | 0.88% | 30 |
|
|
2023
Q4 | $4.8M | Hold |
320,000
| – | – | 1.28% | 22 |
|
|
2023
Q3 | $4.48M | Sell |
320,000
-250,000
| -44% | -$3.5M | 1.46% | 19 |
|
|
2023
Q2 | $5.9M | Buy |
570,000
+65,000
| +13% | +$673K | 1.41% | 19 |
|
|
2023
Q1 | $4.67M | Buy |
505,000
+16,344
| +3% | +$151K | 1.4% | 25 |
|
|
2022
Q4 | $4.33M | Buy |
488,656
+91,156
| +23% | +$809K | 1.51% | 21 |
|
|
2022
Q3 | $3.31M | Buy |
397,500
+158,830
| +67% | +$1.32M | 1.37% | 20 |
|
|
2022
Q2 | $1.96M | Buy |
+238,670
| New | +$1.96M | 0.88% | 28 |
|